Erratum: Vol. 69, No. 39

Related Materials

In the report, “COVID-19 Trends Among School-Aged Children — United States, March 1–September 19, 2020,” the percentage of school-aged children with underlying conditions was calculated using school-aged children for whom one or more underlying conditions was reported as the denominator. Information on underlying conditions is not reported for the vast majority (approximately 80%) of school-aged children included in CDC’s National Notifiable Diseases Surveillance System, so using the total population as the denominator to calculate the percent of children with underlying conditions would substantially underestimate the prevalence of underlying conditions. To correct this, the percentage of school-aged children with underlying conditions was recalculated using school-aged children for whom underlying condition status was known as the denominator (i.e., a “yes” or “no” on case report form, excluding “unknown” and no information).

On page 1410, in the first paragraph, the seventh sentence should have read “Underlying conditions were more common among school-aged children with severe outcomes related to COVID-19: among school-aged children who were hospitalized, admitted to an intensive care unit (ICU), or who died, 23%, 38%, and 33%, respectively, had at least one underlying condition.

On page 1412, in the second column, the first paragraph should have read “Among school-aged children with COVID-19, data about underlying conditions were reported for 59,851 (22%). At least one underlying condition was reported for 17,319 (29%) of those with known underlying condition status, including 11,333 adolescents and 5,986 younger children. Among those with reported data about underlying conditions, chronic lung disease, including asthma, was most commonly reported (7%), followed by disability††† (1%), immunosuppressive conditions (0.9%), diabetes (0.8%), psychological conditions (0.7%), cardiovascular disease (0.6%), and severe obesity (0.5%). At least one underlying condition was reported for 23% of school-aged children who were hospitalized for COVID-19, 38% of those admitted to an ICU, and 33% of those who died.”

On page 1412, there were multiple errors in the Table for the “Underlying conditions” section. Corrections to Table footnotes are bolded. The corrected Table is as follows:

TABLE. Demographic characteristics and underlying conditions among school-aged children aged 5–11 years and 12–17 years* with positive test results for SARS-CoV-2 (N = 233,474) — United States, March 1–September 19, 2020Return to your place in the text
Characteristic Age group, no. (%)
All (N = 277,285) 5–11 yrs (n = 101,503) 12–17 yrs (n = 175,782)
Sex
Female 140,755 (50.8) 50,096 (49.4) 90,659 (51.6)
Male 136,530 (49.2) 51,407 (50.6) 85,123 (48.4)
Median age, yrs 13 8 15
Symptom status
Yes 161,751 (58.3) 56,917 (56.1) 104,834 (59.6)
No 12,806 (4.6) 5,985 (5.9) 6,821 (3.9)
Missing/Unknown 102,728 (37.0) 38,601 (38.0) 64,127 (36.5)
Race/Ethnicity§
Hispanic/Latino 67,275 (41.7) 27,539 (45.9) 39,736 (39.2)
White, non-Hispanic 52,229 (32.4) 15,503 (25.8) 36,726 (36.2)
Black, non-Hispanic 27,963 (17.3) 11,315 (18.8) 16,648 (16.4)
A/PI, non-Hispanic 4,541 (2.8) 1,932 (3.2) 2,609 (2.6)
AI/AN, non-Hispanic 3,044 (1.9) 1,342 (2.2) 1,702 (1.7)
Multiracial/Other race 6,335 (3.9) 2,421 (4.0) 3,914 (3.9)
Unknown 115,898 (N/A) 41,451 (N/A) 74,447 (N/A)
Underlying conditions
Known underlying condition status** 59,851 (21.6) 21,505 (21.2) 38,346 (21.8)
    Any underlying condition 17,319 (28.9) 5,986 (27.8) 11,333 (29.6)
    Chronic lung disease†† 4,214 (7.0) 1,441 (6.7) 2,773 (7.2)
    Disability§§ 714 (1.2) 251 (1.2) 463 (1.2)
    Immunosuppression 526 (0.9) 193 (0.9) 333 (0.9)
    Diabetes mellitus 476 (0.8) 88 (0.4) 388 (1.0)
    Psychological/psychiatric 445 (0.7) 60 (0.3) 385 (1.0)
    Cardiovascular disease 363 (0.6) 128 (0.6) 235 (0.6)
    Current/Former smoker¶¶ 334 (0.6) 11 (0.1) 323 (0.8)
    Severe obesity (BMI ≥40) 315 (0.5) 70 (0.3) 245 (0.6)
    Chronic kidney disease 116 (0.2) 47 (0.2) 69 (0.2)
    Hypertension 94 (0.2) 13 (0.1) 81 (0.2)
    Autoimmune 87 (0.1) 16 (0.1) 71 (0.2)
    Chronic liver disease 64 (0.1) 14 (0.1) 50 (0.1)
    Substance abuse/use 34 (0.1) 0 (0.0) 34 (0.1)
    Other*** 10,907 (18.2) 4,009 (18.6) 6,898 (18.0)
Outcome
Hospitalized††† 3,240 (1.2) 1,021 (1.0) 2,219 (1.3)
ICU admission§§§ 404 (0.1) 145 (0.1) 259 (0.1)
Died¶¶¶ 51 (<0.1) 20 (<0.1) 31 (<0.1)

Abbreviations: A/PI = Asian/Pacific Islander; AI/AN = American Indian/Alaska Native; BMI = body mass index; COVID-19 = coronavirus disease 2019; N/A = not available.
* Age was missing for 1.4% of all persons with positive test results; the proportion aged 5–17 years cannot be determined.
Among 242,259 persons aged 5–17 years with COVID-19, sex was missing, unknown, or other for 8,785 (3.6%).
§ Persons for whom ethnicity was missing (i.e., not reported as either “Hispanic” or “non-Hispanic”) were categorized has having missing race/ethnicity.
Missing data were excluded from the denominator for calculating percentage of each racial/ethnic group. Missing rates did not differ by age group. Multiracial/other race includes persons reported as American Indian/Alaskan Native, Native Hawaiian or other Pacific Islander, multiracial, and persons of another race without further specification.
** Status of underlying conditions known for 59,851 school-aged children: 21,505 aged 5–11 years and 38,346 aged 12–17 years. Status was classified as “known” if any of the following conditions were reported as present or absent: diabetes mellitus, hypertension, severe obesity (BMI ≥40 kg/m2), cardiovascular disease, chronic kidney disease, chronic liver disease, chronic lung disease, immunocompromising condition, autoimmune condition, disability, psychological/psychiatric condition, current or former smoker, substance abuse or use, and other underlying medical condition not otherwise specified. Those with known underlying condition status were used as the denominator for the remaining underlying conditions in the table.
†† Chronic lung disease includes asthma, emphysema, and chronic obstructive pulmonary disease (COPD).
§§ Disability includes neurologic and neurodevelopmental disorders (e.g., seizure disorders, autism spectrum disorders, and developmental delay), intellectual and physical disabilities, vision or hearing impairment, genetic disorders and inherited metabolic disorders, and blood disorders (e.g., sickle cell disease and hemophilia).
¶¶ Checked the box on the case report form for either “current smoker” or “former smoker.”
*** Other includes conditions not listed elsewhere, conditions with no specific autoimmune etiology, endocrine disorders other than diabetes (e.g., polycystic ovarian disease, hypothyroidism, and hyperthyroidism), gastrointestinal disorders (e.g., gastritis or gastresophageal reflux), obstructive sleep apnea, allergies/atopy, anemia (etiology not specified), history of cancer in remission, and other conditions that did not fall under the specified categories.
††† Hospitalization status. 5–11 years: missing/unknown = 44,300 (43.6%); 12–17 years: missing/unknown = 79,411 (45.2%).
§§§ ICU admission status. 5–11 years: missing/unknown = 90,405 (89.0%); 12–17 years: missing/unknown = 154,662 (88.0%).
¶¶¶ Mortality status. 5–11 years: missing/unknown = 47,006 (46.3%); 12–17 years: missing/unknown = 83,479 (47.5%).


Suggested citation for this article: Erratum: Vol. 69, No. 39. MMWR Morb Mortal Wkly Rep 2021;69:1661–1662. DOI: http://dx.doi.org/10.15585/mmwr.mm695152a5.

MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

View Page In: PDF [71K]